News | September 27, 2024
Alkem denies claims of Pan-D, Clavam 625 batches being substandard quality
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
The Notes shall not be offered or sold in India
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
At 10 years, more than one-third (34.0%) of patients with advanced melanoma were alive after treatment with KEYTRUDA, compared to 23.6% of patients treated with ipilimumab
Subscribe To Our Newsletter & Stay Updated
